These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 19504752)
1. Engaging members of African American and Latino communities in preventive HIV vaccine trials. Sobieszczyk ME; Xu G; Goodman K; Lucy D; Koblin BA J Acquir Immune Defic Syndr; 2009 Jun; 51(2):194-201. PubMed ID: 19504752 [TBL] [Abstract][Full Text] [Related]
2. Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City. Ellman TM; Hawkins K; Benitez J; Negron R; Chang S; Palmer S; Robertson V; Chiasson MA; Sobieszczyk ME Vaccine; 2015 Nov; 33(48):6809-15. PubMed ID: 26458799 [TBL] [Abstract][Full Text] [Related]
3. A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016. Huamani KF; Metch B; Broder G; Andrasik M Public Health Rep; 2019; 134(1):72-80. PubMed ID: 30517057 [TBL] [Abstract][Full Text] [Related]
4. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987 [TBL] [Abstract][Full Text] [Related]
5. African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study. Toledo L; McLellan-Lemal E; Arreola S; Campbell C; Sutton M Am J Health Promot; 2014; 29(2):e82-90. PubMed ID: 24432823 [TBL] [Abstract][Full Text] [Related]
6. Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials. Castillo-Mancilla JR; Cohn SE; Krishnan S; Cespedes M; Floris-Moore M; Schulte G; Pavlov G; Mildvan D; Smith KY; HIV Clin Trials; 2014; 15(1):14-26. PubMed ID: 24518211 [TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City. Richardson S; Seekaew P; Koblin B; Vazquez T; Nandi V; Tieu HV PLoS One; 2017; 12(7):e0181702. PubMed ID: 28723970 [TBL] [Abstract][Full Text] [Related]
8. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. Newman PA; Duan N; Roberts KJ; Seiden D; Rudy ET; Swendeman D; Popova S J Acquir Immune Defic Syndr; 2006 Feb; 41(2):210-7. PubMed ID: 16394854 [TBL] [Abstract][Full Text] [Related]
9. HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. Roberts KJ; Newman PA; Duan N; Rudy ET J Natl Med Assoc; 2005 Dec; 97(12):1662-71. PubMed ID: 16396058 [TBL] [Abstract][Full Text] [Related]
10. Enrollment of minority women and their main sexual partners in an HIV/STI prevention trial. Wu E; El-Bassel N; Witte SS; Gilbert L; Chang M; Morse P AIDS Educ Prev; 2005 Feb; 17(1):41-52. PubMed ID: 15843109 [TBL] [Abstract][Full Text] [Related]
11. Regional variation in HIV clinical trials participation in the United States. Heumann C; Cohn SE; Krishnan S; Castillo-Mancilla JR; Cespedes M; Floris-Moore M; Smith KY; South Med J; 2015 Feb; 108(2):107-16. PubMed ID: 25688896 [TBL] [Abstract][Full Text] [Related]
12. Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials. Gwadz MV; Colon P; Ritchie AS; Leonard NR; Cleland CM; Riedel M; Bowens D; Banfield AD; Chang P; Quiles R; Mildvan D Curr HIV/AIDS Rep; 2010 Nov; 7(4):194-200. PubMed ID: 20737252 [TBL] [Abstract][Full Text] [Related]
13. A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru. Andrasik M; Grove D; Broder G; Scott H; Allen M; Karuna S Vaccine; 2019 Jun; 37(29):3911-3917. PubMed ID: 31176538 [TBL] [Abstract][Full Text] [Related]
14. Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Dennis AM; Napravnik S; Seña AC; Eron JJ Clin Infect Dis; 2011 Sep; 53(5):480-7. PubMed ID: 21844031 [TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in HIV vaccine trials: the impact of trial attributes. Newman PA; Duan N; Lee SJ; Rudy E; Seiden D; Kakinami L; Cunningham W Prev Med; 2007 Jun; 44(6):554-7. PubMed ID: 17275895 [TBL] [Abstract][Full Text] [Related]
16. Individual and Neighborhood Characteristics Associated with HIV Among Black and Latino Adults Who Use Drugs and Unaware of Their HIV-Positive Status, New York City, 2000-2004. Lewis CF; Rivera AV; Crawford ND; Gordon K; White K; Vlahov D; Galea S J Racial Ethn Health Disparities; 2016 Dec; 3(4):573-581. PubMed ID: 27294761 [TBL] [Abstract][Full Text] [Related]
17. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US. Brooks RA; Newman PA; Duan N; Ortiz DJ AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857 [TBL] [Abstract][Full Text] [Related]
18. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010. Sionean C; Le BC; Hageman K; Oster AM; Wejnert C; Hess KL; Paz-Bailey G; ; MMWR Surveill Summ; 2014 Dec; 63(14):1-39. PubMed ID: 25522191 [TBL] [Abstract][Full Text] [Related]
19. Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. Allen MA; Liang TS; La Salvia T; Tjugum B; Gulakowski RJ; Murguía M J Acquir Immune Defic Syndr; 2005 Dec; 40(5):617-24. PubMed ID: 16284540 [TBL] [Abstract][Full Text] [Related]
20. Real-World Strategies to Engage and Retain Racial-Ethnic Minority Young Men Who Have Sex with Men in HIV Prevention Services. Freese TE; Padwa H; Oeser BT; Rutkowski BA; Schulte MT AIDS Patient Care STDS; 2017 Jun; 31(6):275-281. PubMed ID: 28530444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]